The harsh microenvironment in infarcted heart accelerates transplanted bone marrow mesenchymal stem cells injury: The role of injured cardiomyocytes-derived exosomes

Cell Death and Disease

Volumn 9, Issue 3, 2018, Pages

  Hu, Ming ^a   Guo, Guixian ^a   Huang, Qiang ^a   Cheng, Chuanfang ^a   Xu, Ruqin ^a   Li, Aiqun ^a   Liu, Ningning ^a   Liu, Shiming ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DNA; HYDROGEN PEROXIDE; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; RAS RELATED PROTEIN RAB 27A; RAB27A PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL CULTURE; CELL DAMAGE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EXOSOME; FEMALE; FLUORESCENCE; GENE EDITING; HEART INFARCTION; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROENVIRONMENT; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; Y CHROMOSOME; ANIMAL; APOPTOSIS; C57BL MOUSE; CYTOLOGY; GENE KNOCKOUT; GENETICS; KNOCKOUT MOUSE; MESENCHYMAL STEM CELL; METABOLISM; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; EXOSOMES; FEMALE; GENE KNOCKOUT TECHNIQUES; HYDROGEN PEROXIDE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RAB27 GTP-BINDING PROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 85042782123     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/s41419-018-0392-5     Document Type: Article

References (49)

1. Herrmann, J. L. et al. Cell-based therapy for ischemic heart disease: A clinical update. Ann. Thorac. Surg. 88, 1714-1722 (2009).
2. Wu, K., Han, Z., Mo, X. & Zhou, B. Cell delivery in cardiac regenerative therapy. Ageing Res. Rev. 11, 32-40 (2012).
3. Liang, X. et al. Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction. Cell Death Dis. 6, e1765 (2015).
4. Cai, M. et al. Bone marrow mesenchymal stem cells (BM-MSCS) improve heart function in swine myocardial infarction model through paracrine effects. Sci. Rep. 6, 28250 (2016).
5. Cao, F. et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113, 1005-1014 (2006).
6. Zhang, S. et al. HIF-2aα and Oct4 have synergistic effects on survival and myocardial repair of very small embryonic-like mesenchymal stem cells in infarcted hearts. Cell Death Dis. 8, e2548 (2017).
7. Mangi, A. A. et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9, 1195-1201 (2003).
8. Chang, W. et al. Mesenchymal stem cells pretreated with delivered Hph-1-Hsp70 protein are protected from hypoxia-mediated cell death and rescue heart functions from myocardial injury. Stem Cells 27, 2283-2292 (2009).
9. Zhang, Z. et al. Autophagy mediates the beneficial effect of hypoxic preconditioning on bone marrow mesenchymal stem cells for the therapy of myocardial infarction. Stem Cell Res. Ther. 8, 89 (2017).
10. Don, C. W. & Murry, C. E. Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts. J. Cell Mol. Med. 17, 1355-1362 (2013).
11. Gitler, A. D., Lu, M., Jiang, Y., Epstein, J. A. & Gruber, P. J. Molecular markers of cardiac endocardial cushion development. Dev. Dyn. 228, 643-650 (2003).
12. Sluijter, J. P., Verhage, V., Deddens, J. C., van den Akker, F. & Doevendans, P. A. Microvesicles and exosomes for intracardiac communication. Cardiovasc. Res. 102, 302-311 (2014).
13. Yanez-Mo, M. et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles 4, 27066 (2015).
14. Kishore, R. & Khan, M. More than tiny sacks: stem cell exosomes as cell-free modality for cardiac repair. Circ. Res. 118, 330-343 (2016).
15. Ostrowski, M. et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 12, 19-30 (2010).
16. Pfeffer, S. R. Two Rabs for exosome release. Nat. Cell Biol. 12, 3-4 (2010).
17. Cosme, J., Liu, P. & Gramolini, A. O. The cardiovascular exosome: current perspectives and potential. Proteomics 13, 1654-1659 (2013).
18. Ishida, M., Arai, S. P., Ohbayashi, N. & Fukuda, M. The GTPase-deficient Rab27A (Q78L) mutant inhibits melanosome transport in melanocytes through trapping of Rab27A effector protein Slac2-A/melanophilin in their cytosol: development of a novel melanosome-targetinG tag. J. Biol. Chem. 289, 11059-11067 (2014).
19. Zeng, L. et al. Bioenergetic and functional consequences of bone marrowderived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation 115, 1866-1875 (2007).
20. Guo, Y. et al. Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction. Basic Res. Cardiol. 112, 18 (2017).
21. Haider, H. & Ashraf, M. Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J. Mol. Cell Cardiol. 45, 554-566 (2008).
22. Chistiakov, D. A., Orekhov, A. N. & Bobryshev, Y. V. Cardiac extracellular vesicles in normal and infarcted heart. Int. J. Mol. Sci. 17, 63 (2016).
23. Cervio, E., Barile, L., Moccetti, T. & Vassalli, G. Exosomes for intramyocardial intercellular communication. Stem Cells Int. 2015, 482171 (2015).
24. Waldenstrom, A., Genneback, N., Hellman, U. & Ronquist, G. Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS ONE 7, e34653 (2012).
25. Wang, X. et al. Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells. J. Mol. Cell Cardiol. 74, 139-150 (2014).
26. Yang, Y. et al. Exosomal transfer of miR-30a between cardiomyocytes regulates autophagy after hypoxia. J. Mol. Med. 94, 711-724 (2016).
27. Huang, H. et al. Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo. Oncotarget 7, 2796-2808 (2016).
28. Morris, G., Walker, A. J., Berk, M., Maes, M. & Puri, B. K. Cell Death Pathways: A Novel Therapeutic Approach for Neuroscientists. Mol. Neurobiol. doi: 10.1007/ s12035-017-0793-y. Epub ahead of print(2017).
29. Liu, N. et al. Calcium channel blocker verapamil accelerates gambogic acidinduced cytotoxicity via enhancing proteasome inhibition and ROS generation. Toxicol. In Vitro 28, 419-425 (2014).
30. Zhang, S. et al. HIF-2alpha and Oct4 have synergistic effects on survival and myocardial repair of very small embryonic-like mesenchymal stem cells in infarcted hearts. Cell Death Dis. 8, e2548 (2017).
31. Bang, C. et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J. Clin. Invest. 124, 2136-2146 (2014).
32. Kervadec, A. et al. Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure. J. Heart Lung Transplant. 35, 795-807 (2016).
33. Halkein, J. et al. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J. Clin. Invest. 123, 2143-2154 (2013).
34. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (2007).
35. Peinado, H. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883-891 (2012).
36. Gupta, S. & Knowlton, A. A. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am. J. Physiol. Heart Circ. Physiol. 292, H3052-H3056 (2007).
37. Malik, Z. A. et al. Cardiac myocyte exosomes: stability, HSP60, and proteomics. Am. J. Physiol. Heart Circ. Physiol. 304, H954-H965 (2013).
38. Kim, S. C. et al. Extracellular heat shock protein 60, cardiac myocytes, and apoptosis. Circ. Res. 105, 1186-1195 (2009).
39. Tian, J. et al. Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes. Cardiovasc. Res. 98, 391-401 (2013).
40. Li, D. et al. Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction. Am. Heart J. 137, 1145-1152 (1999).
41. Yu, X. et al. Mechanism of TNF-alpha autocrine effects in hypoxic cardiomyocytes: initiated by hypoxia inducible factor 1alpha, presented by exosomes. J. Mol. Cell Cardiol. 53, 848-857 (2012).
42. Zhang, M. et al. Bone marrow mesenchymal stem cell transplantation retards the natural senescence of rat hearts. Stem Cells Transl. Med. 4, 494-502 (2015).
43. Liu, N. et al. Ubiquitin-specific protease 14 regulates cardiac hypertrophy progression by increasing GSK-3beta phosphorylation. Biochem. Biophys. Res. Commun. 478, 1236-1241 (2016).
44. Li, P., Kaslan, M., Lee, S. H., Yao, J. & Gao, Z. Progress in exosome isolation techniques. Theranostics 7, 789-804 (2017).
45. Liu, N. et al. The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo. Toxicol. Lett. 224, 333-340 (2014).
46. Boch, J. TALEs of genome targeting. Nat. Biotechnol. 29, 135-136 (2011).
47. Chaturvedi, P., Kalani, A., Medina, I., Familtseva, A. & Tyagi, S. C. Cardiosome mediated regulation of MMP9 in diabetic heart: role of mir29b and mir455 in exercise. J. Cell Mol. Med. 19, 2153-2161 (2015).
48. Huang, J. et al. miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity. PLoS ONE 9, e94382 (2014).
49. Liu, N. et al. Ubiquitin-specific protease 14 regulates LPS-induced inflammation by increasing ERK1/2 phosphorylation and NF-kappaB activation. Mol. Cell Biochem. 431, 87-96 (2017).